Hepatitis Monthly

Published by: Kowsar

Seroprevalence of Hepatitis A Virus among Healthy Individuals in Birjand, Eastern Region of Iran

Neda Mahavar 1 , Mohammad Fereidouni 2 , * and Masood Ziaee 3
Authors Information
1 Department of Immunology, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran
2 Cellular and Molecular Research Center, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran
3 Infectious Diseases Research Center, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran
Article information
  • Hepatitis Monthly: July 2018, 18 (7); e68168
  • Published Online: June 29, 2018
  • Article Type: Brief Report
  • Received: March 2, 2018
  • Revised: May 31, 2018
  • Accepted: June 6, 2018
  • DOI: 10.5812/hepatmon.68168

To Cite: Mahavar N, Fereidouni M, Ziaee M. Seroprevalence of Hepatitis A Virus among Healthy Individuals in Birjand, Eastern Region of Iran, Hepat Mon. 2018 ;18(7):e68168. doi: 10.5812/hepatmon.68168.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
References
  • 1. Hosseini Shokouh SJ, Dadashi A, Abiri M, Zohrevand I, Eshraghian A, Khoshdel A, et al. HAV Immunity in Iranian Medical Students. Hepat Mon. 2015;15(3). e26219. doi: 10.5812/hepatmon.26219. [PubMed: 25825590]. [PubMed Central: PMC4359362].
  • 2. Ahmadi Vasmehjani A, Javeshghani D, Baharlou R, Shayestehpour M, Mousavinasab SD, Joharinia N, et al. Hepatitis A infection in patients with chronic viral liver disease: a cross-sectional study in Jahrom, Iran. Epidemiol Infect. 2015;143(3):534-9. doi: 10.1017/S0950268814000806. [PubMed: 24742346].
  • 3. Chung SJ, Kim TY, Kim SM, Roh M, Yu MY, Lee JH, et al. Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea. Clin Mol Hepatol. 2014;20(2):162-7. doi: 10.3350/cmh.2014.20.2.162. [PubMed: 25032182]. [PubMed Central: PMC4099331].
  • 4. Carrillo-Santisteve P, Tavoschi L, Severi E, Bonfigli S, Edelstein M, Bystrom E, et al. Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review. Lancet Infect Dis. 2017;17(10):e306-19. doi: 10.1016/S1473-3099(17)30392-4. [PubMed: 28645862].
  • 5. Ebrahimzadeh A, Azarkar Z, Ziaee M, Sharifzadeh G, Bijari B. Prevalence and Risk Factors of Hepatitis C Infection (HCV) in Birjand, Iran, 2014. INT J Infection. 2016;3(1). doi: 10.17795/iji-34102.
  • 6. Ziaee M, Ebrahimzadeh A, Azarkar Z, Namaei MH, Saburi A, Fereidouni M, et al. Seroprevalence and Risk Factors for Hepatitis B in an Adult Population: The First Report from Birjand, South Khorasan, Iran. Hepat Mon. 2016;16(9). e36452. doi: 10.5812/hepatmon.36452. [PubMed: 27822260]. [PubMed Central: PMC5090805].
  • 7. Vakili B, Rahimi H, Ataei B, Janghorbani M, Khorvash F, Shoaei P, et al. Hepatitis A seropositivity among newly admitted medical students of Isfahan, Kermanshah, and Hamedan: A seroprevalence study. J Res Med Sci. 2014;19(Suppl 1):S9-S12. [PubMed: 25002901]. [PubMed Central: PMC4078374].
  • 8. Cho HC, Paik SW, Kim YJ, Choi MS, Lee JH, Koh KC, et al. Seroprevalence of anti-HAV among patients with chronic viral liver disease. World J Gastroenterol. 2011;17(2):236-41. doi: 10.3748/wjg.v17.i2.236. [PubMed: 21245998]. [PubMed Central: PMC3020379].
  • 9. Farajzadegan Z, Hoseini SG, Kelishadi R, Jamshidi F, Nokhodian Z, Noori R, et al. Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran. J Res Med Sci. 2014;19(Suppl 1):S56-63. [PubMed: 25002897]. [PubMed Central: PMC4078371].
  • 10. Safiabadi M, Rezaee-Zavareh MS, Alavian SM. Estimation of Hepatitis A Virus Infection Prevalence Among Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Pooled Analysis. Hepat Mon. 2017;17(2). doi: 10.5812/hepatmon.44695.
  • 11. Klevens RM, Denniston MM, Jiles-Chapman RB, Murphy TV. Decreasing immunity to hepatitis A virus infection among US adults: Findings from the National Health and Nutrition Examination Survey (NHANES), 1999-2012. Vaccine. 2015;33(46):6192-8. doi: 10.1016/j.vaccine.2015.10.009. [PubMed: 26476364].
  • 12. Asaei S, Ziyaeyan M, Moeini M, Jamalidoust M, Behzadi MA. Seroprevalence of Hepatitis A and E Virus Infections Among Healthy Population in Shiraz, Southern Iran. Jundishapur J Microbiol. 2015;8(7). e19311. doi: 10.5812/jjm.19311v2. [PubMed: 26421130]. [PubMed Central: PMC4584134].
  • 13. Bura M, Bura A, Adamek A, Michalak M, Marszalek A, Hryckiewicz K, et al. Seroprevalence of hepatitis A virus antibodies (anti-HAV) in adult inhabitants of Wielkopolska region, Poland--the role of simple demographic factors. Ann Agric Environ Med. 2012;19(4):738-41. [PubMed: 23311799].
  • 14. Ataei B, Javadi AA, Nokhodian Z, Kassaeian N, Shoaei P, Farajzadegan Z, et al. HAV in Isfahan province: a population-based study. Trop Gastroenterology. 2010;29(3):160-2.
  • 15. Koff RS. Risks associated with hepatitis A and hepatitis B in patients with hepatitis C. J Clin Gastroenterol. 2001;33(1):20-6. [PubMed: 11418785].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments